ConductScience.org, home

Paper8751986

An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity.

Reasor MJ and 1 other. Proc Soc Exp Biol Med, 1996. Cited by 74 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity. Papers, record 8751986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8751986

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity.
PubMed
Journal
Proc Soc Exp Biol Med
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
2.85
iCite
Revised in PubMed
2020-09-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reasor MJM J
2Kacew SS

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmiodaroneMajor topic
Anti-Arrhythmia AgentsMajor topic
LungMajor topic
Animals
Cell Membrane
Humans
Immune System
Oxidation-Reduction
Phospholipids

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
41640914Amiodarone-Induced Pulmonary Toxicity Presenting as Unilateral Fibrosis: A Case Report.Cureus2026https://conductscience.org/library/papers/41640914PubMed
39803706Artemisinin protected human bronchial epithelial cells from amiodarone-induced oxidative damage via 5'-AMP-activated protein kinase (AMPK) activation.Redox Rep2025https://conductscience.org/library/papers/39803706PubMed
35294757Cell-Based Imaging Assay for Detection of Phospholipidosis.Methods Mol Biol2022https://conductscience.org/library/papers/35294757PubMed
34434327Isolated Neutropenia: An Unexplored Side Effect of Amiodarone.J Med Cases2020https://conductscience.org/library/papers/34434327PubMed
31319538Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary Phospholipidosis.Pharmaceutics2019https://conductscience.org/library/papers/31319538PubMed
28540501Morphometric Characterization of Rat and Human Alveolar Macrophage Cell Models and their Response to Amiodarone using High Content Image Analysis.Pharm Res2017https://conductscience.org/library/papers/28540501PubMed
26933474A Mechanistic Study on the Amiodarone-Induced Pulmonary Toxicity.Oxid Med Cell Longev2016https://conductscience.org/library/papers/26933474PubMed
26544718Coadministration of Atorvastatin and Amiodarone Increases the Risk of Pulmonary Fibrosis in Rats.Med Princ Pract2016https://conductscience.org/library/papers/26544718PubMed
26254911A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data.Eur J Drug Metab Pharmacokinet2016https://conductscience.org/library/papers/26254911PubMed
24563379
Identification of hepatic phospholipidosis inducers in sandwich-cultured rat hepatocytes, a physiologically relevant model, reveals altered basolateral uptake and biliary excretion of anionic probe substrates.
Toxicol Sci2014https://conductscience.org/library/papers/24563379PubMed
24003057Detection of phospholipidosis induction: a cell-based assay in high-throughput and high-content format.J Biomol Screen2014https://conductscience.org/library/papers/24003057PubMed
23568552Pleiotropic actions of amiodarone: still puzzling after half a century.Naunyn Schmiedebergs Arch Pharmacol2013https://conductscience.org/library/papers/23568552PubMed
22651223Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.Respir Res2012https://conductscience.org/library/papers/22651223PubMed
20553056Amiodarone: review of pulmonary effects and toxicity.Drug Saf2010https://conductscience.org/library/papers/20553056PubMed
19675720Acute lung affection in an endurance-trained man under amiodarone medication.Ger Med Sci2005https://conductscience.org/library/papers/19675720PubMed
19568574Role of vitamin-E on rat liver-amiodarone: an ultrastructural study.Saudi J Gastroenterol2009https://conductscience.org/library/papers/19568574PubMed
16782792Interaction of fusidic acid with lipid membranes: Implications to the mechanism of antibiotic activity.Biophys J2006https://conductscience.org/library/papers/16782792PubMed
15855483Mixed-lipid storage disorder induced in macrophages and fibroblasts by oritavancin (LY333328), a new glycopeptide antibiotic with exceptional cellular accumulation.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/15855483PubMed
12890714Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats.Br J Pharmacol2003https://conductscience.org/library/papers/12890714PubMed
11438830Amiodarone and cyclophosphamide: potential for enhanced lung toxicity.Bone Marrow Transplant2001https://conductscience.org/library/papers/11438830PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8751986

GET https://conductscience.org/api/papers/v1/8751986/cited_by?page=2